Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
About this item
Full title
Author / Creator
Vianello, Caterina , Cocetta, Veronica , Catanzaro, Daniela , Dorn, Gerald W , De Milito, Angelo , Rizzolio, Flavio , Canzonieri, Vincenzo , Cecchin, Erika , Roncato, Rossana , Toffoli, Giuseppe , Quagliariello, Vincenzo , Di Mauro, Annabella , Losito, Simona , Maurea, Nicola , Scaffa, Cono , Sales, Gabriele , Scorrano, Luca , Giacomello, Marta and Montopoli, Monica
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Cisplatin (CDDP) is commonly used to treat a multitude of tumors including sarcomas, ovarian and cervical cancers. Despite recent investigations allowed to improve chemotherapy effectiveness, the molecular mechanisms underlying the development of CDDP resistance remain a major goal in cancer research. Here, we show that mitochondrial morphology and...
Alternative Titles
Full title
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
Authors, Artists and Contributors
Author / Creator
Cocetta, Veronica
Catanzaro, Daniela
Dorn, Gerald W
De Milito, Angelo
Rizzolio, Flavio
Canzonieri, Vincenzo
Cecchin, Erika
Roncato, Rossana
Toffoli, Giuseppe
Quagliariello, Vincenzo
Di Mauro, Annabella
Losito, Simona
Maurea, Nicola
Scaffa, Cono
Sales, Gabriele
Scorrano, Luca
Giacomello, Marta
Montopoli, Monica
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d1f77022144740ba9cb329aca83ad24b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1f77022144740ba9cb329aca83ad24b
Other Identifiers
ISSN
2041-4889
E-ISSN
2041-4889
DOI
10.1038/s41419-022-04741-9
